Rate My Professor Joseph Koopmeiners

In recognition of his research accomplishments, leadership, and impact, Koopmeiners was awarded the 2026 Distinguished McKnight University Professorship by the University of Minnesota. He is a member of Delta Omega, the Honorary Society in Public Health, and participates in the American Statistical Association, International Biometrics Society, and Society for Clinical Trials. His scholarly influence is substantial, with over 6,430 citations documented on Google Scholar, where he is identified as Professor of Biostatistics. Notable publications include 'A randomized, controlled trial of ZMapp for Ebola virus infection' (New England Journal of Medicine, 2016), 'Randomized trial of reduced-nicotine standards for cigarettes' (New England Journal of Medicine, 2015), 'Safety and immunogenicity of a nicotine conjugate vaccine in current smokers' (Clinical Pharmacology & Therapeutics, 2005), 'Identification of seven new prostate cancer susceptibility loci through a genome-wide association study' (Nature Genetics, 2009), and 'Effect of immediate vs gradual reduction in nicotine content of cigarettes on biomarkers of smoke exposure: a randomized clinical trial' (JAMA, 2018).